<table width="95%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 3:  Population Pharmacokinetic Estimates of Darunavir as Darunavir 800 mg Coadministered with Ritonavir 100 mg Once Daily (Trial TMC114-C211, 48 Week Analysis and Trial TMC114-C229, 48 Week Analysis) and Darunavir 800 mg coadministered with cobicistat 150 mg Once Daily (Study GS-US-216-130, 24 Week Analysis)</caption>
<col align="left" valign="top" width="25%"></col>
<col align="center" valign="top" width="25%"></col>
<col align="center" valign="top" width="25%"></col>
<col align="center" valign="top" width="25%"></col>
<thead>
<tr>
<th align="center">Parameter</th>
<th>Trial TMC114-C211 <br/>(treatment-naïve)<br/> Darunavir 800 mg coadministered with ritonavir 100 mg once daily</th>
<th>Trial TMC114-C229 <br/>(treatment-experienced) <br/>Darunavir 800 mg coadministered with ritonavir 100 mg once daily</th>
<th>Trial GS-US-216-0130 <br/>(treatment-naïve and experienced)<br/>Darunavir 800 mg coadministered with cobicistat 150 mg once daily</th>
</tr>
<tr>
<th></th>
<th valign="bottom">N=335</th>
<th valign="bottom">N=280</th>
<th valign="bottom">N=298</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="4">N=number of subjects with data</td>
</tr>
</tfoot>
<tbody>
<tr>
<td>AUC<sub>24h</sub> (ng∙h/mL)</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>  Mean ± Standard Deviation</td>
<td>93026 ± 27050</td>
<td>93334 ± 28626</td>
<td>100152 ± 32042</td>
</tr>
<tr>
<td>  Median (Range)</td>
<td>87854<br/>(45000–219240)</td>
<td>87788<br/>(45456–236920)</td>
<td>96900<br/>(34500–224000)</td>
</tr>
<tr>
<td>C<sub>0h</sub> (ng/mL)</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>  Mean ± Standard Deviation</td>
<td>2282 ± 1168</td>
<td>2160 ± 1201</td>
<td>2043 ± 1257</td>
</tr>
<tr>
<td>  Median (Range)</td>
<td>2041<br/>(368–7242)</td>
<td>1896<br/>(184–7881)</td>
<td>1875<br/>(70–6890)</td>
</tr>
</tbody>
</table>